Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Galmed Pharmaceuticals Ltd.

Publish new data on Aramchol's mechanism of action in JHEP Reports

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
26 Jan 2021
Due
28 Jan 2021
Delivered
28 Jan 2021
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“The paper is expected to be published in the JHEP Reports on January 28, 2021.”

What we found

Evidence strength A What the grades mean

The company confirmed the publication of the paper regarding Aramchol's mechanism of action in JHEP Reports, which occurred in early 2021.

  • A
    Galmed Pharmaceuticals Ltd. 6-K filed 2021-03-18 Regulatory filing · published 18 Mar 2021 · retrieved 25 Oct 2026 · kept permanently by the SEC · fingerprint a9462529956e
    “A new paper entitled "Aramchol Downregulates Stearoyl CoA-Desaturase 1 (SCD1) in Hepatic Stellate Cells to Attenuate Cellular Fibrogenesis" was published in the JHEP Reports.” ✓ confirmed on the page

Market reaction: the shares moved +12.0% against the S&P 500 over the three sessions around the disclosure (17 Mar 2021 to 22 Mar 2021). What this measures

Checked 25 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Publish
Deliverable
Aramchol mechanism of action paper
Language
Expected (“expects”, “plans”)
In the company’s control
High
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “no_evidence”.
  4. Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the recorded outcome.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Galmed Pharmaceuticals Ltd.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-EOCN-022398 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.